Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
3
×
cancer
3
×
national blog main
biotech
boston
clinical trials
life sciences
national top stories
startups
texas blog main
texas top stories
abbvie
akouos
allergan
alnylam pharmaceuticals
amag pharmaceuticals
amunix
andrew berens
anirvan ghosh
astrazeneca
australia
avapritinib
bill mckeon
biogen
blueprint medicines
bluerock therapeutics
boulder/denver blog main
boulder/denver top stories
cancer immunotherapy
cerovene
commercialization
covid-19
crispr
deals
deciphera pharmaceuticals
deerfield management
detroit blog main
detroit top stories
drugs
durvalumab
What
announced
3
×
plans
acquisitions
approval
bio
blueprint
cancer
center
center’s
ceo
chasing
collabs
covid
daniel
deadly
deal
deciphera
director
drug
fda
filing
forms
gi
gilead
gilead’s
head
help
houston
innovation
institute
introduce
ipo
jlabs
luby
medical
medicine
medicines
month
morning
named
Language
unset
Current search:
announced
×
" boston blog main "
×
cancer
×
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
4 years ago
Chasing Blueprint, Deciphera Plans FDA Filing for GI Cancer Drug
@xconomy.com
5 years ago
JLabs’ Luby Takes the Reins at TMC Innovation Institute in Houston